Abstract Interleukin-8 (IL-8) is a chemokine produced by a variety of cell types involved in atherogenesis and is chemotactic for neutrophils and lymphocytes. A recent study has shown that IL-8 is angiogenic and induces proliferation and chemotaxis of endothelial cells. The present study was undertaken to find out whether IL-8 is also mitogenic and chemotactic for vascular smooth muscle cells. IL-8 induced a concentration-dependent (0.1 to 10 nmol/L) stimulation of DNA synthesis and cell proliferation in both human and rat aortic smooth muscle cells. In addition, IL-8 stimulated smooth muscle cells to produce prostaglandin E2, which can inhibit IL-8-induced smooth muscle cell proliferation. In the presence of indomethacin (5 gmol/L), (1 nmol/L) stimulated an increase in human and rat aortic smooth muscle cell number during a 3-day period of incubation by 61±16% and 59±7% (n=4), respectively. IL-8 also increased DNA synthesis in human and rat aortic smooth muscle cells by 98±10% and 151±27% (n=5), respectively. Moreover, IL-8 stimulated rat aortic smooth muscle cell migration by 20-fold over the control value, with an EC,0 value of 0.83 nmol/L; this chemotactic activity of IL-8 was also potentiated by indomethacin. Exposure of smooth muscle cells to IL-8 caused rapid and transient expression of the immediate-early genes c-fos and zif268 mRNA. The maximal levels of c-fos and zif268 mRNA in human and rat aortic smooth muscle cells were observed 30 minutes and 1 hour after stimulation with IL-8, respectively, followed by rapid decline. Moreover, IL-8 stimulated mitogenactivated protein (MAP) kinase in smooth muscle cells with a peak at 5 to 10 minutes after stimulation. At 1 and 10 nmol/L IL-8, MAP kinase activity increased by 1.5-and 7-fold above the basal level, respectively. Since vascular smooth muscle cell proliferation and migration are crucial steps in neointimal formation in restenosis and atherosclerosis, these results suggest that IL-8 may be an important naturally occurring mitogen and chemoattractant for vascular smooth muscle cells and may play a role in the pathogenesis of arterial intimal thickening and atherosclerosis. (Circ Res. 1994;75:1-7.) 
V ascular smooth muscle is the predominant cell type in the media of the normal mammalian artery and as such provides the vasculature with structural support and vasomotion. In vascular injury, such as that following balloon angioplasty, the vascular smooth muscle cells (VSMCs) migrate from the media to the intima and then proliferate and secrete excessive matrix proteins. These processes are thought to play a pivotal role in the development of chronic atherosclerosis and in restenosis after angioplasty of human coronary arteries (see Reference 1 for review). However, the mechanisms responsible for these abnormal changes are still incompletely understood. An increasing body of evidence has indicated that cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF) may modulate local pathological processes including atherosclerosis (see Reference 2 for review). This hypothesis emerges from the observations that each of the principal cell types involved in atherogenesis both produces and responds to a variety of cytokines. Like the growth factors, cytokines are expressed at low or undetectable levels in normal animal or human arterial tissue but are increased after injury or in atherosclerotic lesions. 34 There are several examples of an association between expression of particular cytokines and lesions of atherosclerosis. They alter key functions of vascular cells5"6 that likely contribute to the atherogenic process at many junctures. Moreover, it has been reported that cytokines such as IL-1 also activate VSMCs to produce other cytokines or growth factors. 7, 8 Thus, cytokines derived from lesion cells may contribute to multiple aspects of atheroma initiation, progression, and complication.
Interleukin-8 (IL-8) is a monocyte/macrophage-derived peptide that belongs to a novel cytokine family of 8-to 10-kD molecular mass. Fourteen distinct members have currently been assigned to this subfamily. 
Cell Culture
RASMCs were isolated and cultured as reported previously. 12 Briefly, RASMCs were isolated from medial explants from the thoracic aorta of male Sprague-Dawley rats (300 to 350 g) (Charles River) and cultured in DMEM (GIBCO) supplemented with 10% FBS and gentamicin (50 ,ig/mL). Smooth muscle cells (SMCs) were allowed to grow out from the tissue, which was consequently removed. After confluence was reached, cells were harvested by brief trypsination and subcultured in T-150 flasks or 24-well plates. The purity of the VSMCs was estimated to be >90% by cell morphology and the immunoexpression of myosin, as described previously.12 HASMCs as cryopreserved tertiary culture (MyoPack-AOSMC) were provided by Clonetics Corp and subcultured in smooth muscle growth medium containing human epidermal growth factor (10 ng/mL), human fibroblast growth factor (2 ng/mL), dexamethasone (0.39 ,ug/mL), 5% FBS, gentamicin (50 ,g/mL), and amphotericin-B (50 ng/mL) in T-150 flasks. The growth medium was changed every other day until confluence was reached. Both HASMCs and RASMCs under passage 6 were used in the present study.
DNA Synthesis
DNA synthesis in SMCs was assessed by measurement of the incorporation of [3H]thymidine into the cells, as reported previously.12 Briefly, VSMCs were grown in 24-well plates to ':"70% to 80% confluence and then made quiescent with DMEM containing insulin (5 pg/mL), transferrin (5 ,ug/mL), and sodium selenite (5 ng/mL) for 48 hours. Unless otherwise indicated, the cells were incubated with indomethacin (5 ,umol/L) for 20 minutes and then challenged with IL-8 for 24 hours.
[3H]Thymidine (0.5 ,uCi per well) was added for a further 4-hour incubation. DNA synthesis was assessed by measuring the radioactivity incorporated into the trichloracetic acid-insoluble fraction of the cells.
Mitogenic Assay
VSMCs were subcultured into 24-well plates to reach 60% to 70% confluence and then made quiescent, as described above. The cells were stimulated by IL-8 for 3 to 5 days in the presence of indomethacin (5 ,mol/L), unless otherwise described. At the end of incubation, medium was removed, and cells were treated with 0.25 mL of 0.05% trypsin-0.53 mmol/L EDTA, harvested, and counted.
Cell Migration Assay RASMC migration was monitored in a Transwell cell culture chamber by using a polycarbonate membrane with pores of 8 gm (Costar), as reported previously.13 Briefly, SMCs were suspended in DMEM supplemented with 0.2% bovine serum albumin at a concentration of 2.5 x 106 cells per milliliter. In the standard assay, 0.2 mL of cell suspension was placed in the upper compartment of the chamber. The lower compartment contained 0.6 mL of DMEM supplemented with 0.2% bovine serum albumin and IL-8 or vehicle. Incubation was at 37°C in an atmosphere of 95% air/5% CO2 for 24 hours. After incubation, nonmigrated cells on the upper surface were scraped gently, and the filters were fixed in methanol and stained with 10% Giemsa stain. The number of SMCs that had migrated to the lower surface of the filters was determined microscopically, and four high-power fields (x 100) were counted per filter. Experiments were performed in duplicate or triplicate.
PGE2 Assay
HASMCs cultured in 24-well plates were challenged with IL-8 in the presence or absence of indomethacin (5 ,umol/L) for 48 hours. PGE2 released from HASMCs into the medium was extracted with ethyl acetate (pH 3 to 4) and determined by use of a PGE2 1'I radioimmunoassay kit (Amersham) as per the manufacturer's instructions.
Northern Blot Analysis
Total cellular RNA was prepared from serum-deprived and IL-8-stimulated VSMCs by using an acid guanidinium thiocyanate, phenol, and chloroform extraction procedure.14 RNA samples (10 ,tg per lane) were electrophoresed through formaldehyde-agarose slab gels15 and transferred to GeneScreen Plus membranes (Du Pont-New England Nuclear). Northern hybridization to the cDNA probes of c-fos16 (a gift of R. Taub, University of Pennsylvania), zif26817 (a gift of B.A. Christy, University of Texas Health Science Center at San Antonio), and ribosomal protein L32 cDNA18 (a gift of R.P. Perry, Institute for Cancer Research) was described previously. 19 Briefly, cDNA fragments for probes were isolated by restriction enzyme digestions followed by electrophoresis. DNA probes were uniformly labeled with [a-32P]dATP by using a random-priming DNA labeling kit (Boehringer Mannheim). Hybridization was carried out overnight with 1x 106 cpm/mL of probe at 42°C in 5 x SSPE buffer (750 mmol/L NaCl, 50 mmol/L NaH2PO4 [pH 7.6], and 5 mmol/L EDTA), 50%
formamide, Denhardt's solution, 2% sodium dodecyl sulfate (SDS), and 200 ,ug/mL boiled salmon sperm DNA. The membranes were washed in 2x SSPE and 2% SDS at 65°C for 1 to 2 hours with a change every 30 minutes and then autoradiographed at -70°C with a Cronex Lightning-Plus intensifying screen for various times, depending on the signal intensity. Phosphorlmager was used to quantify the band intensities of the Northern blots, which were analyzed with IMAGEQUANT-TM Software v3.0 (Molecular Dynamics). The probes were stripped from the membranes by boiling in 10 mmol/L Tris (pH 7.5), 1 mmol/L EDTA (pH 8.0), and 1% SDS for 20 minutes before rehybridization with another probe.
Mitogen-Activated Protein Kinase Assay
RASMCs were made quiescent for 48 hours in DMEM. Fresh DMEM was added before the addition of IL-8 or vehicle, and cells were further incubated for 5 minutes or at the indicated time with IL-8. Incubation medium was decanted, and cell monolayers were washed once with cold Dulbecco's phosphate-buffered saline containing 1 mmol/L control value, respectively. Under the same conditions,
IL-1,B (10 nmol/L)-induced increases in HASMC and
RASMC proliferation were 94±+-30% (n=3) and 96±24% (n=5) over the control value, respectively. In the absence of indomethacin, the responses of the VSMCs to IL-8 were significantly reduced and quite variable (Fig 1) .
IL Two critical immediate-early genes, c-fos and zif268, were selected to monitor the IL-8-induced cellular proliferation of SMCs. The mRNA levels of these two genes in unstimulated RASMCs were almost undetectable and rapidly induced by IL-8, as shown in Fig 4. The maximal levels of c-fos and zif268 mRNAs were ob- shown in Fig 6A, Fig 5, the potency of IL-8 in modulating both c-fos and zif268 message levels was lower than that of PDGF or IL-1,; this finding also coincides with the results observed in promoting cell proliferation by Protein-tyrosine phosphorylation has been considered to be involved in cell proliferation, because several oncogene products and a number of growth factor receptors possess a tyrosine kinase activity.34 MAP kinase, a serine/threonine-specific protein kinase, has been found to be activated in many proliferative cells in factors or oncogenes and is one of the most widely studied tyrosine-phosphorylated proteins.35'36 Recently, MAP kinase has been shown to phosphorylate in vitro the products of the proto-oncogenes c-fos, c-jun, and c-myc.3738 Since IL-8 has been shown in the present study to stimulate VSMC proliferation and the expression of the proto-oncogenes, we were interested in exploring whether MAP kinase is involved in IL-8-stimulated VSMCs. As shown in Fig 6, IL-8 at 1 and 10 nmol/L stimulated MAP kinase activity. The activation was detectable as early as 2 minutes, peaked at 5 to 10 minutes, and declined to nearly the basal level 30 minutes after stimulation. MAP kinase was activated by IL-8 in a concentration-dependent manner (Fig 6) ; however, the maximal effect was shown at an IL-8 concentration of 10 nmol/L, which was higher than that required for stimulating cell proliferation and migration. The exact reason for this difference is not known at present. The possibility is that even the modest extent of MAP kinase activation by IL-8 at low concentrations is sufficient to induce the maximal increase in cell proliferation and migration. The peptide APRTPGGRR, which constitutes a MAP kinase phosphorylation site in myelin basic protein, was used as a substrate for MAP kinase assay in the present study. This peptide is now used more frequently by investigators in the field because of its apparent specificity over myelin basic protein.39-41 However, there is no published data so far suggesting it to be absolutely specific for MAP kinase. Whether other serine/threonine kinases can be activated by IL-8 and also phosphorylate the myelin basic protein peptide is not known. This possibility cannot be completely eliminated at the present time. MAP kinase is considered to play an important role as an intermediate in the signaling pathways from receptor to the ribosomes and nucleus. However, the precise role of IL-8-induced MAP kinase activation in signal transduction in VSMCs remains to be clarified until the IL-8 receptor in VSMCs is characterized and specific inhibitors of MAP kinase become available.
In summary, IL-8 is a mitogen and chemoattractant for VSMCs. IL-8 stimulates VSMCs to release PGs that modulate both VSMC proliferation and migration. IL-8 rapidly and transiently induces proto-oncogene c-fos and zif268 expression and activates MAP kinase in VSMCs. These results suggest that IL-8 may be an important naturally occurring mitogen and chemoattractant for VSMCs and that it plays a role in arterial intimal thickening.
